{"product_id":"jxr-fertility-business-model-canvas","title":"Jinxin Fertility Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eJinxin Fertility: Business Model Unveiled!\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eCurious about Jinxin Fertility's winning formula? Our Business Model Canvas breaks down their customer relationships, revenue streams, and key resources, offering a clear roadmap to their success. Discover the strategic advantages that position them as a leader in the fertility market.\u003c\/p\u003e\n\u003cp\u003eUnlock the complete strategic blueprint behind Jinxin Fertility's business model. This in-depth Business Model Canvas reveals how the company drives value, captures market share, and stays ahead in a competitive landscape. Ideal for entrepreneurs, consultants, and investors looking for actionable insights.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Equity Investments\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eJinxin Fertility strategically enhances its business model through equity investments in key partners. A prime example is its significant shareholder stake in PT Morula Indonesia, acquired in July 2024. This move underscores a deliberate strategy to expand its reach and capabilities.\u003c\/p\u003e\n\u003cp\u003eThis partnership with PT Morula Indonesia is designed to harness shared expertise and tap into the burgeoning Southeast Asian IVF market. It represents a crucial element of Jinxin Fertility's growth strategy, moving beyond solely organic expansion to include synergistic collaborations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFinancial Investment Funds\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eJinxin Fertility’s strategic alliance with Warburg Pincus, solidified in November 2023, positions the company as a limited partner within their investment fund. This collaboration is specifically crafted to bolster Jinxin Fertility's capacity for identifying and pursuing acquisition targets.  By leveraging the fund's extensive resources and market reach, Jinxin Fertility aims to conduct more comprehensive and in-depth explorations of potential growth avenues.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedical Referral Networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eJinxin Fertility cultivates robust relationships with a broad spectrum of medical professionals, encompassing obstetricians, gynecologists, and general practitioners. These collaborations are fundamental for generating a consistent stream of patient referrals for assisted reproductive services.\u003c\/p\u003e\n\u003cp\u003eThese strategic alliances are vital for bolstering Jinxin Fertility's footprint within local markets. For instance, in 2024, the company reported a 15% increase in patient acquisition directly attributed to its established medical referral network, highlighting the significant impact of these partnerships on business growth.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Academic Collaborations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eJinxin Fertility's HRC Medical actively engages in research and academic collaborations to drive innovation and talent development. A prime example is their partnership with the Keck School of Medicine of the University of Southern California, focusing on training future IVF specialists. These collaborations are crucial for building a robust pipeline of skilled professionals and pushing the boundaries of reproductive medicine.\u003c\/p\u003e\n\u003cp\u003eSuch academic alliances not only ensure a continuous supply of highly trained personnel but also foster an environment of ongoing research and development. This synergy between clinical practice and academic inquiry allows for the rapid integration of new findings and techniques into patient care, ultimately benefiting those seeking fertility treatments.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eTalent Pipeline:\u003c\/strong\u003e Collaborations with institutions like Keck School of Medicine ensure a steady stream of trained IVF specialists.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdvancement in Reproductive Medicine:\u003c\/strong\u003e Partnerships foster research and development, leading to improved fertility treatments.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eKnowledge Exchange:\u003c\/strong\u003e These alliances facilitate the sharing of expertise and best practices between clinical and academic settings.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnology and Equipment Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eJinxin Fertility strategically partners with providers of advanced Assisted Reproductive Technology (ART) equipment, laboratory technology, and genetic screening tools. These collaborations are fundamental to upholding Jinxin's high standards of patient care and ensuring access to state-of-the-art medical devices. For instance, in 2024, Jinxin continued its relationships with leading global suppliers of incubators, microscopes, and cryopreservation systems, crucial for successful IVF cycles.\u003c\/p\u003e\n\u003cp\u003eThese alliances are not just about acquiring equipment; they are about continuous improvement in treatment efficacy. By working closely with technology providers, Jinxin gains early access to innovations and can influence the development of next-generation ART solutions. This ensures that their laboratories are equipped with the most efficient and reliable technology available, contributing to higher success rates in fertility treatments.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\u003cstrong\u003ePartnerships with leading ART equipment manufacturers ensure Jinxin Fertility utilizes the latest innovations in incubators, microscopes, and laboratory consumables.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eCollaborations with genetic screening technology providers enable Jinxin to offer advanced preimplantation genetic testing (PGT) services.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eThese key partnerships are vital for maintaining Jinxin's competitive edge and delivering superior patient outcomes in the rapidly evolving fertility market.\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Partnerships Drive Growth and Innovation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eJinxin Fertility's key partnerships are crucial for both market expansion and technological advancement. The equity investment in PT Morula Indonesia, a significant step taken in July 2024, directly targets the growing Southeast Asian IVF market, leveraging shared expertise. Furthermore, the strategic alliance with Warburg Pincus, established in November 2023, enhances Jinxin's ability to identify and pursue acquisition opportunities by tapping into the fund's resources.\u003c\/p\u003e\n\u003cp\u003eThese collaborations extend to a vital network of medical professionals, including obstetricians, gynecologists, and general practitioners, who are instrumental in generating patient referrals. In 2024, Jinxin observed a 15% rise in patient acquisition stemming directly from this medical referral network, underscoring its importance for business growth.\u003c\/p\u003e\n\u003cp\u003eAcademic partnerships, such as the one with the Keck School of Medicine of the University of Southern California, are essential for talent development, ensuring a pipeline of skilled IVF specialists and fostering innovation in reproductive medicine.\u003c\/p\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA comprehensive overview of Jinxin Fertility's business model, detailing its customer segments, value propositions, and key resources to support strategic decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eJinxin Fertility's Business Model Canvas acts as a pain point reliever by streamlining complex fertility journey logistics, offering clarity and actionable steps.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAssisted Reproductive Services (ARS) Delivery\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eJinxin Fertility's primary activity is delivering a broad spectrum of assisted reproductive services (ARS). This includes in vitro fertilization (IVF), intrauterine insemination (IUI), egg retrieval, embryo transfer, and crucial genetic screening.\u003c\/p\u003e\n\u003cp\u003eThe company is deeply committed to improving success rates across all its procedures. In 2024, Jinxin Fertility reported a significant increase in IVF success rates, with live birth rates per embryo transfer reaching an average of 55% for women under 35, a figure that benchmarks favorably against industry averages.\u003c\/p\u003e\n\u003cp\u003eFurthermore, Jinxin is actively expanding its service portfolio to support patients throughout their entire fertility journey. This expansion includes enhanced pre-implantation genetic testing (PGT) options and advanced cryopreservation techniques, ensuring comprehensive care from initial consultation to successful pregnancy.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinic Operations and Expansion\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eJinxin Fertility's core activities revolve around managing and strategically expanding its network of fertility centers and hospitals. This includes both establishing new facilities and enhancing existing ones to meet growing demand.\u003c\/p\u003e\n\u003cp\u003eA key part of this expansion strategy is the opening of new satellite centers, such as HRC Medical's Beverly Hills facility, which commenced operations in July 2024. Concurrently, a business development hub was established in San Francisco in December 2024 to drive future growth and partnerships.\u003c\/p\u003e\n\u003cp\u003eThese expansion efforts necessitate significant operational focus on recruiting top-tier physicians and overseeing the construction and equipping of new clinics. This ensures Jinxin Fertility can effectively increase its service capacity and reach more patients in both China and the United States.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Development (R\u0026amp;D) in ART\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eJinxin Fertility heavily invests in Research and Development (R\u0026amp;D) to pioneer advanced assisted reproductive technologies. A key focus is on developing novel techniques, such as the pull-out method specifically designed for male azoospermia patients, and sophisticated embryonic protein screening technology. These advancements are crucial for enhancing treatment efficacy and expanding the range of specialized services offered.\u003c\/p\u003e\n\u003cp\u003eThe company's commitment to continuous innovation directly translates into improved success rates for fertility treatments. By staying at the forefront of diagnostic and therapeutic methodologies, Jinxin Fertility aims to provide patients with the most effective and cutting-edge solutions available in the field of reproductive medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Mergers and Acquisitions (M\u0026amp;A)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eJinxin Fertility actively pursues strategic mergers and acquisitions to broaden its operational footprint, with a particular focus on markets exhibiting strong growth potential within China and Southeast Asia. This proactive approach aims to consolidate market position and leverage synergies across its expanding network.\u003c\/p\u003e\n\u003cp\u003eRecent strategic moves underscore this objective. In 2023, Jinxin Fertility acquired controlling interests in Jiuzhou Hospital and Hewanjia Hospital. These acquisitions are designed to significantly enhance its market share and service reach within the Southwest China region, a key growth area for fertility services.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eExpansion Strategy:\u003c\/strong\u003e Targeting high-growth markets in China and Southeast Asia for M\u0026amp;A opportunities.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRecent Acquisitions:\u003c\/strong\u003e Gained controlling stakes in Jiuzhou Hospital and Hewanjia Hospital.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMarket Impact:\u003c\/strong\u003e Aims to solidify and expand market share, particularly in Southwest China.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePatient Outreach and Education\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eJinxin Fertility actively engages in marketing and patient education to highlight its services and increase awareness of fertility treatment options. This proactive approach aims to attract new patients and foster trust in the brand.\u003c\/p\u003e\n\u003cp\u003eThe company utilizes a multi-channel strategy, including a strong online presence, participation in health expos, and hosting educational seminars. These efforts are crucial for reaching a wider audience and addressing potential patients' concerns.\u003c\/p\u003e\n\u003cp\u003eIn 2024, Jinxin Fertility reported a significant increase in website traffic following targeted digital marketing campaigns. Furthermore, attendance at their educational seminars saw a 25% year-over-year rise, indicating growing patient interest in fertility solutions.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eOnline Presence:\u003c\/strong\u003e Targeted social media campaigns and SEO optimization to reach potential patients seeking fertility information.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHealth Expos:\u003c\/strong\u003e Participation in major health and wellness events to directly engage with individuals and couples.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEducational Seminars:\u003c\/strong\u003e Hosting informative sessions led by fertility specialists to demystify treatment processes and answer patient questions.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBrand Trust:\u003c\/strong\u003e Building credibility through patient testimonials and transparent communication about success rates and procedures.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAchieving 55% Live Births: Expanding Fertility Services Globally\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eJinxin Fertility's key activities center on providing comprehensive assisted reproductive services, including IVF and genetic screening, with a strong emphasis on improving success rates. In 2024, their live birth rates per embryo transfer for women under 35 reached 55%, demonstrating their commitment to effective treatment. The company also focuses on expanding its service portfolio and network of fertility centers, both domestically and internationally, to cater to a growing patient base.\u003c\/p\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eDelivered as Displayed\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe Jinxin Fertility Business Model Canvas you are previewing is the exact document you will receive upon purchase. This isn't a sample or mockup; it's a direct snapshot of the complete, ready-to-use file. You'll gain full access to this professionally structured and detailed canvas, allowing you to immediately begin analyzing and strategizing for Jinxin Fertility.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":55674838057337,"sku":"jxr-fertility-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/jxr-fertility-business-model-canvas.png?v=1755796372","url":"https:\/\/portersfiveforce.com\/products\/jxr-fertility-business-model-canvas","provider":"Porter's Five Forces","version":"1.0","type":"link"}